newsfilter
← Latest News
GlobeNewswire·

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ((", ALX Oncology, ", NASDAQ:ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies